4.5 Article

Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Spinal cord atrophy in spinocerebellar ataxia type 3 and 6 -: Impact on clinical disability

Carsten Lukas et al.

JOURNAL OF NEUROLOGY (2008)

Article Clinical Neurology

Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study

W Rashid et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)

Article Clinical Neurology

Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients

V Hoffmann et al.

EUROPEAN JOURNAL OF NEUROLOGY (2006)

Article Clinical Neurology

Inflammation and atrophy in multiple sclerosis: MRI associations with disease course

X Lin et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)